ProtonDx

London, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a portable molecular diagnostic platform designed to deliver rapid, laboratory-grade testing at the point of need. ProtonDx is based in London, United Kingdom and was founded in 2020. It has raised $11.4 million.

Last price · $/share
—
Implied valuation
—
Total raised
$11.4M
Last round
—
Valuation — not yet established

No valuation for ProtonDx is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($11.4M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ProtonDx with a free account
  • ·Watch ProtonDx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ProtonDx funding history

No rounds on record

No funding rounds for ProtonDx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How ProtonDx's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For ProtonDx, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about ProtonDx

How much has ProtonDx raised?
ProtonDx has raised $11.4M in total funding across its recorded rounds.